Shopping Cart 0
Cart Subtotal
AED 0

Global Flu (Influenza) Vaccine Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 12478

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 22754

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 22754

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 22754

Details

The Flu (Influenza) Vaccine market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Flu (Influenza) Vaccine market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Flu (Influenza) Vaccine market. The report focuses on well-known providers in the global Flu (Influenza) Vaccine industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Flu (Influenza) Vaccine Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Flu (Influenza) Vaccine market covered in Chapter 4:

Bavarian Nordic

Mitsubishi Tanabe Pharma

Novavax

Pfizer

Inovio Pharmaceuticals

CSL (Novartis)

GlaxoSmithKline

Emergent BioSolutions

Merck & Co

Sanofi Pasteur

In Chapter 11 and 13.3, on the basis of types, the Flu (Influenza) Vaccine market from 2015 to 2026 is primarily split into:

Inactivated Influenza Vaccines (IIV)

Live Attenuated Influenza Vaccines (LAIV)

In Chapter 12 and 13.4, on the basis of applications, the Flu (Influenza) Vaccine market from 2015 to 2026 covers:

For Children (6 months to 3 years)

For Adults and Children over 3 years

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

READ MORE

Table Of Content

Scope

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Flu (Influenza) Vaccine Market Share by Type (2020-2026)

1.5.2 Inactivated Influenza Vaccines (IIV)

1.5.3 Live Attenuated Influenza Vaccines (LAIV)

1.6 Market by Application

1.6.1 Global Flu (Influenza) Vaccine Market Share by Application (2020-2026)

1.6.2 For Children (6 months to 3 years)

1.6.3 For Adults and Children over 3 years

1.7 Flu (Influenza) Vaccine Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Flu (Influenza) Vaccine Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 PorteraEUR s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Flu (Influenza) Vaccine Market

3.1 Value Chain Status

3.2 Flu (Influenza) Vaccine Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Flu (Influenza) Vaccine

3.2.3 Labor Cost of Flu (Influenza) Vaccine

3.2.3.1 Labor Cost of Flu (Influenza) Vaccine Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Bavarian Nordic

4.1.1 Bavarian Nordic Basic Information

4.1.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.1.3 Bavarian Nordic Flu (Influenza) Vaccine Market Performance (2015-2020)

4.1.4 Bavarian Nordic Business Overview

4.2 Mitsubishi Tanabe Pharma

4.2.1 Mitsubishi Tanabe Pharma Basic Information

4.2.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.2.3 Mitsubishi Tanabe Pharma Flu (Influenza) Vaccine Market Performance (2015-2020)

4.2.4 Mitsubishi Tanabe Pharma Business Overview

4.3 Novavax

4.3.1 Novavax Basic Information

4.3.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.3.3 Novavax Flu (Influenza) Vaccine Market Performance (2015-2020)

4.3.4 Novavax Business Overview

4.4 Pfizer

4.4.1 Pfizer Basic Information

4.4.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.4.3 Pfizer Flu (Influenza) Vaccine Market Performance (2015-2020)

4.4.4 Pfizer Business Overview

4.5 Inovio Pharmaceuticals

4.5.1 Inovio Pharmaceuticals Basic Information

4.5.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.5.3 Inovio Pharmaceuticals Flu (Influenza) Vaccine Market Performance (2015-2020)

4.5.4 Inovio Pharmaceuticals Business Overview

4.6 CSL (Novartis)

4.6.1 CSL (Novartis) Basic Information

4.6.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.6.3 CSL (Novartis) Flu (Influenza) Vaccine Market Performance (2015-2020)

4.6.4 CSL (Novartis) Business Overview

4.7 GlaxoSmithKline

4.7.1 GlaxoSmithKline Basic Information

4.7.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.7.3 GlaxoSmithKline Flu (Influenza) Vaccine Market Performance (2015-2020)

4.7.4 GlaxoSmithKline Business Overview

4.8 Emergent BioSolutions

4.8.1 Emergent BioSolutions Basic Information

4.8.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.8.3 Emergent BioSolutions Flu (Influenza) Vaccine Market Performance (2015-2020)

4.8.4 Emergent BioSolutions Business Overview

4.9 Merck & Co

4.9.1 Merck & Co Basic Information

4.9.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.9.3 Merck & Co Flu (Influenza) Vaccine Market Performance (2015-2020)

4.9.4 Merck & Co Business Overview

4.10 Sanofi Pasteur

4.10.1 Sanofi Pasteur Basic Information

4.10.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.10.3 Sanofi Pasteur Flu (Influenza) Vaccine Market Performance (2015-2020)

4.10.4 Sanofi Pasteur Business Overview

5 Global Flu (Influenza) Vaccine Market Analysis by Regions

5.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Regions

5.1.1 Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)

5.1.2 Global Flu (Influenza) Vaccine Revenue by Regions (2015-2020)

5.2 North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

5.3 Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

5.6 South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

6 North America Flu (Influenza) Vaccine Market Analysis by Countries

6.1 North America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries

6.1.1 North America Flu (Influenza) Vaccine Sales by Countries (2015-2020)

6.1.2 North America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)

6.1.3 North America Flu (Influenza) Vaccine Market Under COVID-19

6.2 United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

6.2.1 United States Flu (Influenza) Vaccine Market Under COVID-19

6.3 Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

6.4 Mexico Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7 Europe Flu (Influenza) Vaccine Market Analysis by Countries

7.1 Europe Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020)

7.1.2 Europe Flu (Influenza) Vaccine Revenue by Countries (2015-2020)

7.1.3 Europe Flu (Influenza) Vaccine Market Under COVID-19

7.2 Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.2.1 Germany Flu (Influenza) Vaccine Market Under COVID-19

7.3 UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.3.1 UK Flu (Influenza) Vaccine Market Under COVID-19

7.4 France Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.4.1 France Flu (Influenza) Vaccine Market Under COVID-19

7.5 Italy Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.5.1 Italy Flu (Influenza) Vaccine Market Under COVID-19

7.6 Spain Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.6.1 Spain Flu (Influenza) Vaccine Market Under COVID-19

7.7 Russia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.7.1 Russia Flu (Influenza) Vaccine Market Under COVID-19

8 Asia-Pacific Flu (Influenza) Vaccine Market Analysis by Countries

8.1 Asia-Pacific Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Flu (Influenza) Vaccine Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Flu (Influenza) Vaccine Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Flu (Influenza) Vaccine Market Under COVID-19

8.2 China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.2.1 China Flu (Influenza) Vaccine Market Under COVID-19

8.3 Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.3.1 Japan Flu (Influenza) Vaccine Market Under COVID-19

8.4 South Korea Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.4.1 South Korea Flu (Influenza) Vaccine Market Under COVID-19

8.5 Australia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.6 India Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.6.1 India Flu (Influenza) Vaccine Market Under COVID-19

8.7 Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Flu (Influenza) Vaccine Market Under COVID-19

9 Middle East and Africa Flu (Influenza) Vaccine Market Analysis by Countries

9.1 Middle East and Africa Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Flu (Influenza) Vaccine Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Flu (Influenza) Vaccine Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Flu (Influenza) Vaccine Market Under COVID-19

9.2 Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

9.3 UAE Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

9.4 Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

9.5 Nigeria Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

9.6 South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

10 South America Flu (Influenza) Vaccine Market Analysis by Countries

10.1 South America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries

10.1.1 South America Flu (Influenza) Vaccine Sales by Countries (2015-2020)

10.1.2 South America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)

10.1.3 South America Flu (Influenza) Vaccine Market Under COVID-19

10.2 Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

10.2.1 Brazil Flu (Influenza) Vaccine Market Under COVID-19

10.3 Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

10.4 Columbia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

10.5 Chile Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

11 Global Flu (Influenza) Vaccine Market Segment by Types

11.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Types (2015-2020)

11.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Types (2015-2020)

11.2 Inactivated Influenza Vaccines (IIV) Sales and Price (2015-2020)

11.3 Live Attenuated Influenza Vaccines (LAIV) Sales and Price (2015-2020)

12 Global Flu (Influenza) Vaccine Market Segment by Applications

12.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Applications (2015-2020)

12.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Applications (2015-2020)

12.2 For Children (6 months to 3 years) Sales, Revenue and Growth Rate (2015-2020)

12.3 For Adults and Children over 3 years Sales, Revenue and Growth Rate (2015-2020)

13 Flu (Influenza) Vaccine Market Forecast by Regions (2020-2026)

13.1 Global Flu (Influenza) Vaccine Sales, Revenue and Growth Rate (2020-2026)

13.2 Flu (Influenza) Vaccine Market Forecast by Regions (2020-2026)

13.2.1 North America Flu (Influenza) Vaccine Market Forecast (2020-2026)

13.2.2 Europe Flu (Influenza) Vaccine Market Forecast (2020-2026)

13.2.3 Asia-Pacific Flu (Influenza) Vaccine Market Forecast (2020-2026)

13.2.4 Middle East and Africa Flu (Influenza) Vaccine Market Forecast (2020-2026)

13.2.5 South America Flu (Influenza) Vaccine Market Forecast (2020-2026)

13.3 Flu (Influenza) Vaccine Market Forecast by Types (2020-2026)

13.4 Flu (Influenza) Vaccine Market Forecast by Applications (2020-2026)

13.5 Flu (Influenza) Vaccine Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source


List Of Figure

List of Tables and Figures

Table Global Flu (Influenza) Vaccine Market Size Growth Rate by Type (2020-2026)

Figure Global Flu (Influenza) Vaccine Market Share by Type in 2019 & 2026

Figure Inactivated Influenza Vaccines (IIV) Features

Figure Live Attenuated Influenza Vaccines (LAIV) Features

Table Global Flu (Influenza) Vaccine Market Size Growth by Application (2020-2026)

Figure Global Flu (Influenza) Vaccine Market Share by Application in 2019 & 2026

Figure For Children (6 months to 3 years) Description

Figure For Adults and Children over 3 years Description

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Flu (Influenza) Vaccine Industry Development

Table SWOT Analysis

Figure Porter's Five Forces Analysis

Figure Global Flu (Influenza) Vaccine Market Size and Growth Rate 2015-2026

Table Industry News

Table Industry Policies

Figure Value Chain Status of Flu (Influenza) Vaccine

Figure Production Process of Flu (Influenza) Vaccine

Figure Manufacturing Cost Structure of Flu (Influenza) Vaccine

Figure Major Company Analysis (by Business Distribution Base, by Product Type)

Table Downstream Major Customer Analysis (by Region)

Table Bavarian Nordic Profile

Table Bavarian Nordic Production, Value, Price, Gross Margin 2015-2020

Table Mitsubishi Tanabe Pharma Profile

Table Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2015-2020

Table Novavax Profile

Table Novavax Production, Value, Price, Gross Margin 2015-2020

Table Pfizer Profile

Table Pfizer Production, Value, Price, Gross Margin 2015-2020

Table Inovio Pharmaceuticals Profile

Table Inovio Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020

Table CSL (Novartis) Profile

Table CSL (Novartis) Production, Value, Price, Gross Margin 2015-2020

Table GlaxoSmithKline Profile

Table GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020

Table Emergent BioSolutions Profile

Table Emergent BioSolutions Production, Value, Price, Gross Margin 2015-2020

Table Merck & Co Profile

Table Merck & Co Production, Value, Price, Gross Margin 2015-2020

Table Sanofi Pasteur Profile

Table Sanofi Pasteur Production, Value, Price, Gross Margin 2015-2020

Figure Global Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Global Flu (Influenza) Vaccine Revenue (USD ) and Growth (2015-2020)

Table Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)

Table Global Flu (Influenza) Vaccine Sales Market Share by Regions (2015-2020)

Table Global Flu (Influenza) Vaccine Revenue (USD ) by Regions (2015-2020)

Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions (2015-2020)

Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2015

Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2019

Figure North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure North America Flu (Influenza) Vaccine Revenue (USD ) and Growth (2015-2020)

Table North America Flu (Influenza) Vaccine Sales by Countries (2015-2020)

Table North America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)

Figure North America Flu (Influenza) Vaccine Sales Market Share by Countries in 2015

Figure North America Flu (Influenza) Vaccine Sales Market Share by Countries in 2019

Table North America Flu (Influenza) Vaccine Revenue (USD ) by Countries (2015-2020)

Table North America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)

Figure North America Flu (Influenza) Vaccine Revenue Market Share by Countries in 2015

Figure North America Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019

Figure United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Mexico Flu (Influenza) Vaccine Sales and Growth (2015-2020)

Figure Europe Flu (Influenza) Vaccine Revenue (USD ) Growth (2015-2020)

Table Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020)

Table Europe Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)

Figure Europe Flu (Influenza) Vaccine Sales Market Share by Countries in 2015

Figure Europe Flu (Influenza) Vaccine Sales Market Share by Countries in 2019

Table Europe Flu (Influenza) Vaccine Revenue (USD ) by Countries (2015-2020)

Table Europe Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)

Figure Europe Flu (Influenza) Vaccine Revenue Market Share by Countries in 2015

Figure Europe Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019

Figure Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure France Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Italy Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Spain Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Russia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Flu (Influenza) Vaccine Revenue (USD ) and Growth (2015-2020)

Table Asia-Pacific Flu (Influenza) Vaccine Sales by Countries (2015-2020)

Table Asia-Pacific Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)

Figure Asia-Pacific Flu (Influenza) Vaccine Sales Market Share by Countries in 2015

Figure Asia-Pacific Flu (Influenza) Vaccine Sales Market Share by Countries in 2019

Table Asia-Pacific Flu (Influenza) Vaccine Revenue (USD ) by Countries (2015-2020)

Table Asia-Pacific Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)

Figure Asia-Pacific Flu (Influenza) Vaccine Revenue Market Share by Countries in 2015

Figure Asia-Pacific Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019

Figure China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure South Korea Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Australia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure India Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Flu (Influenza) Vaccine Revenue (USD ) and Growth (2015-2020)

Table Middle East and Africa Flu (Influenza) Vaccine Sales by Countries (2015-2020)

Table Middle East and Africa Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Flu (Influenza) Vaccine Revenue (USD ) by Countries (2015-2020)

Table Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)

Figure Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Countries in 2015

Figure Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019

Figure Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure UAE Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Nigeria Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure South America Flu (Influenza) Vaccine Revenue (USD ) and Growth (2015-2020)

Table South America Flu (Influenza) Vaccine Sales by Countries (2015-2020)

Table South America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)

Table South America Flu (Influenza) Vaccine Revenue (USD ) by Countries (2015-2020)

Table South America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)

Figure South America Flu (Influenza) Vaccine Revenue Market Share by Countries in 2015

Figure South America Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019

Figure Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Columbia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Chile Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Table Global Flu (Influenza) Vaccine Sales by Types (2015-2020)

Table Global Flu (Influenza) Vaccine Sales Share by Types (2015-2020)

Table Global Flu (Influenza) Vaccine Revenue (USD ) by Types (2015-2020)

Table Global Flu (Influenza) Vaccine Revenue Share by Types (2015-2020)

Figure Global Inactivated Influenza Vaccines (IIV) Sales and Growth Rate (2015-2020)

Figure Global Inactivated Influenza Vaccines (IIV) Price (2015-2020)

Figure Global Live Attenuated Influenza Vaccines (LAIV) Sales and Growth Rate (2015-2020)

Figure Global Live Attenuated Influenza Vaccines (LAIV) Price (2015-2020)

Table Global Flu (Influenza) Vaccine Sales by Applications (2015-2020)

Table Global Flu (Influenza) Vaccine Sales Share by Applications (2015-2020)

Figure Global For Children (6 months to 3 years) Sales and Growth Rate (2015-2020)

Figure Global For Children (6 months to 3 years) Revenue and Growth Rate (2015-2020)

Figure Global For Adults and Children over 3 years Sales and Growth Rate (2015-2020)

Figure Global For Adults and Children over 3 years Revenue and Growth Rate (2015-2020)

Figure Global Flu (Influenza) Vaccine Sales and Growth Rate (2020-2026)

Figure Global Flu (Influenza) Vaccine Revenue (USD ) and Growth Rate (2020-2026)

Table Global Flu (Influenza) Vaccine Sales Forecast by Regions (2020-2026)

Table Global Flu (Influenza) Vaccine Revenue Forecast by Regions (2020-2026)

Figure North America Flu (Influenza) Vaccine Sales Forecast (2020-2026)

Figure North America Flu (Influenza) Vaccine Revenue Forecast (2020-2026)

Figure Europe Flu (Influenza) Vaccine Sales Forecast (2020-2026)

Figure Europe Flu (Influenza) Vaccine Revenue Forecast (2020-2026)

Figure Asia-Pacific Flu (Influenza) Vaccine Sales Forecast (2020-2026)

Figure Asia-Pacific Flu (Influenza) Vaccine Revenue Forecast (2020-2026)

Figure Middle East and Africa Flu (Influenza) Vaccine Sales Forecast (2020-2026)

Figure Middle East and Africa Flu (Influenza) Vaccine Revenue Forecast (2020-2026)

Figure South America Flu (Influenza) Vaccine Sales Forecast (2020-2026)

Figure South America Flu (Influenza) Vaccine Revenue Forecast (2020-2026)

Table Global Flu (Influenza) Vaccine Sales Forecast by Types (2020-2026)

Table Global Flu (Influenza) Vaccine Sales Market Share Forecast by Types (2020-2026)

Table Global Flu (Influenza) Vaccine Revenue Forecast by Types (2020-2026)

Table Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Types (2020-2026)

Table Global Flu (Influenza) Vaccine Sales Forecast by Applications (2020-2026)

Table Global Flu (Influenza) Vaccine Sales Market Share Forecast by Applications (2020-2026)

Table Global Flu (Influenza) Vaccine Revenue Forecast by Applications (2020-2026)

Table Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Applications (2020-2026)

Licence Rights

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The Flu (Influenza) Vaccine market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Flu (Influenza) Vaccine market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Flu (Influenza) Vaccine market. The report focuses on well-known providers in the global Flu (Influenza) Vaccine industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Flu (Influenza) Vaccine Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Flu (Influenza) Vaccine market covered in Chapter 4:

Bavarian Nordic

Mitsubishi Tanabe Pharma

Novavax

Pfizer

Inovio Pharmaceuticals

CSL (Novartis)

GlaxoSmithKline

Emergent BioSolutions

Merck & Co

Sanofi Pasteur

In Chapter 11 and 13.3, on the basis of types, the Flu (Influenza) Vaccine market from 2015 to 2026 is primarily split into:

Inactivated Influenza Vaccines (IIV)

Live Attenuated Influenza Vaccines (LAIV)

In Chapter 12 and 13.4, on the basis of applications, the Flu (Influenza) Vaccine market from 2015 to 2026 covers:

For Children (6 months to 3 years)

For Adults and Children over 3 years

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

READ MORE

Scope

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Flu (Influenza) Vaccine Market Share by Type (2020-2026)

1.5.2 Inactivated Influenza Vaccines (IIV)

1.5.3 Live Attenuated Influenza Vaccines (LAIV)

1.6 Market by Application

1.6.1 Global Flu (Influenza) Vaccine Market Share by Application (2020-2026)

1.6.2 For Children (6 months to 3 years)

1.6.3 For Adults and Children over 3 years

1.7 Flu (Influenza) Vaccine Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Flu (Influenza) Vaccine Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 PorteraEUR s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Flu (Influenza) Vaccine Market

3.1 Value Chain Status

3.2 Flu (Influenza) Vaccine Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Flu (Influenza) Vaccine

3.2.3 Labor Cost of Flu (Influenza) Vaccine

3.2.3.1 Labor Cost of Flu (Influenza) Vaccine Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Bavarian Nordic

4.1.1 Bavarian Nordic Basic Information

4.1.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.1.3 Bavarian Nordic Flu (Influenza) Vaccine Market Performance (2015-2020)

4.1.4 Bavarian Nordic Business Overview

4.2 Mitsubishi Tanabe Pharma

4.2.1 Mitsubishi Tanabe Pharma Basic Information

4.2.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.2.3 Mitsubishi Tanabe Pharma Flu (Influenza) Vaccine Market Performance (2015-2020)

4.2.4 Mitsubishi Tanabe Pharma Business Overview

4.3 Novavax

4.3.1 Novavax Basic Information

4.3.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.3.3 Novavax Flu (Influenza) Vaccine Market Performance (2015-2020)

4.3.4 Novavax Business Overview

4.4 Pfizer

4.4.1 Pfizer Basic Information

4.4.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.4.3 Pfizer Flu (Influenza) Vaccine Market Performance (2015-2020)

4.4.4 Pfizer Business Overview

4.5 Inovio Pharmaceuticals

4.5.1 Inovio Pharmaceuticals Basic Information

4.5.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.5.3 Inovio Pharmaceuticals Flu (Influenza) Vaccine Market Performance (2015-2020)

4.5.4 Inovio Pharmaceuticals Business Overview

4.6 CSL (Novartis)

4.6.1 CSL (Novartis) Basic Information

4.6.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.6.3 CSL (Novartis) Flu (Influenza) Vaccine Market Performance (2015-2020)

4.6.4 CSL (Novartis) Business Overview

4.7 GlaxoSmithKline

4.7.1 GlaxoSmithKline Basic Information

4.7.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.7.3 GlaxoSmithKline Flu (Influenza) Vaccine Market Performance (2015-2020)

4.7.4 GlaxoSmithKline Business Overview

4.8 Emergent BioSolutions

4.8.1 Emergent BioSolutions Basic Information

4.8.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.8.3 Emergent BioSolutions Flu (Influenza) Vaccine Market Performance (2015-2020)

4.8.4 Emergent BioSolutions Business Overview

4.9 Merck & Co

4.9.1 Merck & Co Basic Information

4.9.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.9.3 Merck & Co Flu (Influenza) Vaccine Market Performance (2015-2020)

4.9.4 Merck & Co Business Overview

4.10 Sanofi Pasteur

4.10.1 Sanofi Pasteur Basic Information

4.10.2 Flu (Influenza) Vaccine Product Profiles, Application and Specification

4.10.3 Sanofi Pasteur Flu (Influenza) Vaccine Market Performance (2015-2020)

4.10.4 Sanofi Pasteur Business Overview

5 Global Flu (Influenza) Vaccine Market Analysis by Regions

5.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Regions

5.1.1 Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)

5.1.2 Global Flu (Influenza) Vaccine Revenue by Regions (2015-2020)

5.2 North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

5.3 Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

5.6 South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

6 North America Flu (Influenza) Vaccine Market Analysis by Countries

6.1 North America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries

6.1.1 North America Flu (Influenza) Vaccine Sales by Countries (2015-2020)

6.1.2 North America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)

6.1.3 North America Flu (Influenza) Vaccine Market Under COVID-19

6.2 United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

6.2.1 United States Flu (Influenza) Vaccine Market Under COVID-19

6.3 Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

6.4 Mexico Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7 Europe Flu (Influenza) Vaccine Market Analysis by Countries

7.1 Europe Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020)

7.1.2 Europe Flu (Influenza) Vaccine Revenue by Countries (2015-2020)

7.1.3 Europe Flu (Influenza) Vaccine Market Under COVID-19

7.2 Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.2.1 Germany Flu (Influenza) Vaccine Market Under COVID-19

7.3 UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.3.1 UK Flu (Influenza) Vaccine Market Under COVID-19

7.4 France Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.4.1 France Flu (Influenza) Vaccine Market Under COVID-19

7.5 Italy Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.5.1 Italy Flu (Influenza) Vaccine Market Under COVID-19

7.6 Spain Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.6.1 Spain Flu (Influenza) Vaccine Market Under COVID-19

7.7 Russia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

7.7.1 Russia Flu (Influenza) Vaccine Market Under COVID-19

8 Asia-Pacific Flu (Influenza) Vaccine Market Analysis by Countries

8.1 Asia-Pacific Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Flu (Influenza) Vaccine Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Flu (Influenza) Vaccine Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Flu (Influenza) Vaccine Market Under COVID-19

8.2 China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.2.1 China Flu (Influenza) Vaccine Market Under COVID-19

8.3 Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.3.1 Japan Flu (Influenza) Vaccine Market Under COVID-19

8.4 South Korea Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.4.1 South Korea Flu (Influenza) Vaccine Market Under COVID-19

8.5 Australia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.6 India Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.6.1 India Flu (Influenza) Vaccine Market Under COVID-19

8.7 Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Flu (Influenza) Vaccine Market Under COVID-19

9 Middle East and Africa Flu (Influenza) Vaccine Market Analysis by Countries

9.1 Middle East and Africa Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Flu (Influenza) Vaccine Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Flu (Influenza) Vaccine Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Flu (Influenza) Vaccine Market Under COVID-19

9.2 Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

9.3 UAE Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

9.4 Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

9.5 Nigeria Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

9.6 South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

10 South America Flu (Influenza) Vaccine Market Analysis by Countries

10.1 South America Flu (Influenza) Vaccine Sales, Revenue and Market Share by Countries

10.1.1 South America Flu (Influenza) Vaccine Sales by Countries (2015-2020)

10.1.2 South America Flu (Influenza) Vaccine Revenue by Countries (2015-2020)

10.1.3 South America Flu (Influenza) Vaccine Market Under COVID-19

10.2 Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

10.2.1 Brazil Flu (Influenza) Vaccine Market Under COVID-19

10.3 Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

10.4 Columbia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

10.5 Chile Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

11 Global Flu (Influenza) Vaccine Market Segment by Types

11.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Types (2015-2020)

11.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Types (2015-2020)

11.2 Inactivated Influenza Vaccines (IIV) Sales and Price (2015-2020)

11.3 Live Attenuated Influenza Vaccines (LAIV) Sales and Price (2015-2020)

12 Global Flu (Influenza) Vaccine Market Segment by Applications

12.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Applications (2015-2020)

12.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Applications (2015-2020)

12.2 For Children (6 months to 3 years) Sales, Revenue and Growth Rate (2015-2020)

12.3 For Adults and Children over 3 years Sales, Revenue and Growth Rate (2015-2020)

13 Flu (Influenza) Vaccine Market Forecast by Regions (2020-2026)

13.1 Global Flu (Influenza) Vaccine Sales, Revenue and Growth Rate (2020-2026)

13.2 Flu (Influenza) Vaccine Market Forecast by Regions (2020-2026)

13.2.1 North America Flu (Influenza) Vaccine Market Forecast (2020-2026)

13.2.2 Europe Flu (Influenza) Vaccine Market Forecast (2020-2026)

13.2.3 Asia-Pacific Flu (Influenza) Vaccine Market Forecast (2020-2026)

13.2.4 Middle East and Africa Flu (Influenza) Vaccine Market Forecast (2020-2026)

13.2.5 South America Flu (Influenza) Vaccine Market Forecast (2020-2026)

13.3 Flu (Influenza) Vaccine Market Forecast by Types (2020-2026)

13.4 Flu (Influenza) Vaccine Market Forecast by Applications (2020-2026)

13.5 Flu (Influenza) Vaccine Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source


List Of Figure

List of Tables and Figures

Table Global Flu (Influenza) Vaccine Market Size Growth Rate by Type (2020-2026)

Figure Global Flu (Influenza) Vaccine Market Share by Type in 2019 & 2026

Figure Inactivated Influenza Vaccines (IIV) Features

Figure Live Attenuated Influenza Vaccines (LAIV) Features

Table Global Flu (Influenza) Vaccine Market Size Growth by Application (2020-2026)

Figure Global Flu (Influenza) Vaccine Market Share by Application in 2019 & 2026

Figure For Children (6 months to 3 years) Description

Figure For Adults and Children over 3 years Description

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Flu (Influenza) Vaccine Industry Development

Table SWOT Analysis

Figure Porter's Five Forces Analysis

Figure Global Flu (Influenza) Vaccine Market Size and Growth Rate 2015-2026

Table Industry News

Table Industry Policies

Figure Value Chain Status of Flu (Influenza) Vaccine

Figure Production Process of Flu (Influenza) Vaccine

Figure Manufacturing Cost Structure of Flu (Influenza) Vaccine

Figure Major Company Analysis (by Business Distribution Base, by Product Type)

Table Downstream Major Customer Analysis (by Region)

Table Bavarian Nordic Profile

Table Bavarian Nordic Production, Value, Price, Gross Margin 2015-2020

Table Mitsubishi Tanabe Pharma Profile

Table Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2015-2020

Table Novavax Profile

Table Novavax Production, Value, Price, Gross Margin 2015-2020

Table Pfizer Profile

Table Pfizer Production, Value, Price, Gross Margin 2015-2020

Table Inovio Pharmaceuticals Profile

Table Inovio Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020

Table CSL (Novartis) Profile

Table CSL (Novartis) Production, Value, Price, Gross Margin 2015-2020

Table GlaxoSmithKline Profile

Table GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020

Table Emergent BioSolutions Profile

Table Emergent BioSolutions Production, Value, Price, Gross Margin 2015-2020

Table Merck & Co Profile

Table Merck & Co Production, Value, Price, Gross Margin 2015-2020

Table Sanofi Pasteur Profile

Table Sanofi Pasteur Production, Value, Price, Gross Margin 2015-2020

Figure Global Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Global Flu (Influenza) Vaccine Revenue (USD ) and Growth (2015-2020)

Table Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)

Table Global Flu (Influenza) Vaccine Sales Market Share by Regions (2015-2020)

Table Global Flu (Influenza) Vaccine Revenue (USD ) by Regions (2015-2020)

Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions (2015-2020)

Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2015

Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2019

Figure North America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Europe Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure South America Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure North America Flu (Influenza) Vaccine Revenue (USD ) and Growth (2015-2020)

Table North America Flu (Influenza) Vaccine Sales by Countries (2015-2020)

Table North America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)

Figure North America Flu (Influenza) Vaccine Sales Market Share by Countries in 2015

Figure North America Flu (Influenza) Vaccine Sales Market Share by Countries in 2019

Table North America Flu (Influenza) Vaccine Revenue (USD ) by Countries (2015-2020)

Table North America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)

Figure North America Flu (Influenza) Vaccine Revenue Market Share by Countries in 2015

Figure North America Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019

Figure United States Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Canada Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Mexico Flu (Influenza) Vaccine Sales and Growth (2015-2020)

Figure Europe Flu (Influenza) Vaccine Revenue (USD ) Growth (2015-2020)

Table Europe Flu (Influenza) Vaccine Sales by Countries (2015-2020)

Table Europe Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)

Figure Europe Flu (Influenza) Vaccine Sales Market Share by Countries in 2015

Figure Europe Flu (Influenza) Vaccine Sales Market Share by Countries in 2019

Table Europe Flu (Influenza) Vaccine Revenue (USD ) by Countries (2015-2020)

Table Europe Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)

Figure Europe Flu (Influenza) Vaccine Revenue Market Share by Countries in 2015

Figure Europe Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019

Figure Germany Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure UK Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure France Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Italy Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Spain Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Russia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Flu (Influenza) Vaccine Revenue (USD ) and Growth (2015-2020)

Table Asia-Pacific Flu (Influenza) Vaccine Sales by Countries (2015-2020)

Table Asia-Pacific Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)

Figure Asia-Pacific Flu (Influenza) Vaccine Sales Market Share by Countries in 2015

Figure Asia-Pacific Flu (Influenza) Vaccine Sales Market Share by Countries in 2019

Table Asia-Pacific Flu (Influenza) Vaccine Revenue (USD ) by Countries (2015-2020)

Table Asia-Pacific Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)

Figure Asia-Pacific Flu (Influenza) Vaccine Revenue Market Share by Countries in 2015

Figure Asia-Pacific Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019

Figure China Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Japan Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure South Korea Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Australia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure India Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Flu (Influenza) Vaccine Revenue (USD ) and Growth (2015-2020)

Table Middle East and Africa Flu (Influenza) Vaccine Sales by Countries (2015-2020)

Table Middle East and Africa Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Flu (Influenza) Vaccine Revenue (USD ) by Countries (2015-2020)

Table Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)

Figure Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Countries in 2015

Figure Middle East and Africa Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019

Figure Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure UAE Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Nigeria Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure South America Flu (Influenza) Vaccine Revenue (USD ) and Growth (2015-2020)

Table South America Flu (Influenza) Vaccine Sales by Countries (2015-2020)

Table South America Flu (Influenza) Vaccine Sales Market Share by Countries (2015-2020)

Table South America Flu (Influenza) Vaccine Revenue (USD ) by Countries (2015-2020)

Table South America Flu (Influenza) Vaccine Revenue Market Share by Countries (2015-2020)

Figure South America Flu (Influenza) Vaccine Revenue Market Share by Countries in 2015

Figure South America Flu (Influenza) Vaccine Revenue Market Share by Countries in 2019

Figure Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Columbia Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Figure Chile Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)

Table Global Flu (Influenza) Vaccine Sales by Types (2015-2020)

Table Global Flu (Influenza) Vaccine Sales Share by Types (2015-2020)

Table Global Flu (Influenza) Vaccine Revenue (USD ) by Types (2015-2020)

Table Global Flu (Influenza) Vaccine Revenue Share by Types (2015-2020)

Figure Global Inactivated Influenza Vaccines (IIV) Sales and Growth Rate (2015-2020)

Figure Global Inactivated Influenza Vaccines (IIV) Price (2015-2020)

Figure Global Live Attenuated Influenza Vaccines (LAIV) Sales and Growth Rate (2015-2020)

Figure Global Live Attenuated Influenza Vaccines (LAIV) Price (2015-2020)

Table Global Flu (Influenza) Vaccine Sales by Applications (2015-2020)

Table Global Flu (Influenza) Vaccine Sales Share by Applications (2015-2020)

Figure Global For Children (6 months to 3 years) Sales and Growth Rate (2015-2020)

Figure Global For Children (6 months to 3 years) Revenue and Growth Rate (2015-2020)

Figure Global For Adults and Children over 3 years Sales and Growth Rate (2015-2020)

Figure Global For Adults and Children over 3 years Revenue and Growth Rate (2015-2020)

Figure Global Flu (Influenza) Vaccine Sales and Growth Rate (2020-2026)

Figure Global Flu (Influenza) Vaccine Revenue (USD ) and Growth Rate (2020-2026)

Table Global Flu (Influenza) Vaccine Sales Forecast by Regions (2020-2026)

Table Global Flu (Influenza) Vaccine Revenue Forecast by Regions (2020-2026)

Figure North America Flu (Influenza) Vaccine Sales Forecast (2020-2026)

Figure North America Flu (Influenza) Vaccine Revenue Forecast (2020-2026)

Figure Europe Flu (Influenza) Vaccine Sales Forecast (2020-2026)

Figure Europe Flu (Influenza) Vaccine Revenue Forecast (2020-2026)

Figure Asia-Pacific Flu (Influenza) Vaccine Sales Forecast (2020-2026)

Figure Asia-Pacific Flu (Influenza) Vaccine Revenue Forecast (2020-2026)

Figure Middle East and Africa Flu (Influenza) Vaccine Sales Forecast (2020-2026)

Figure Middle East and Africa Flu (Influenza) Vaccine Revenue Forecast (2020-2026)

Figure South America Flu (Influenza) Vaccine Sales Forecast (2020-2026)

Figure South America Flu (Influenza) Vaccine Revenue Forecast (2020-2026)

Table Global Flu (Influenza) Vaccine Sales Forecast by Types (2020-2026)

Table Global Flu (Influenza) Vaccine Sales Market Share Forecast by Types (2020-2026)

Table Global Flu (Influenza) Vaccine Revenue Forecast by Types (2020-2026)

Table Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Types (2020-2026)

Table Global Flu (Influenza) Vaccine Sales Forecast by Applications (2020-2026)

Table Global Flu (Influenza) Vaccine Sales Market Share Forecast by Applications (2020-2026)

Table Global Flu (Influenza) Vaccine Revenue Forecast by Applications (2020-2026)

Table Global Flu (Influenza) Vaccine Revenue Market Share Forecast by Applications (2020-2026)

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS